HistoSonics Targets Surgeon Engagement at AHPBA Meeting With Focus on Edison System

A LinkedIn post from HistoSonics highlights the company’s planned presence at the AHPBA Annual Meeting in Miami Beach, Fla., from March 19–22. The post promotes an evening dinner forum titled “Histotripsy in Practice: A Clinical Forum,” featuring surgical oncologist Young K. Hong of MD Anderson Cancer Center at Cooper as speaker.

According to the post, the event targets current and emerging histotripsy users and requires advance RSVP due to limited space. The company also notes that its team will be available at exhibition booth Nos. 32 and 33 to discuss the Edison Histotripsy System, with a disclaimer that use outside liver applications is currently limited to clinical investigations.

For investors, the post suggests an emphasis on clinician engagement and education around histotripsy, which could support adoption of the Edison System over time. Active participation at a specialty conference like AHPBA may help HistoSonics build relationships with key opinion leaders in hepatobiliary surgery, potentially strengthening its competitive position in image-guided therapeutic technologies.

The focus on liver applications and the explicit disclaimer about investigational use elsewhere indicate that the commercial opportunity may still be concentrated in a narrow set of indications. Nonetheless, increased visibility among surgeons and ongoing clinical use could lay groundwork for future label expansions, reimbursement progress, and broader revenue potential if subsequent trials are successful.